Skip to main content
SpringerLink
Log in

Maternal Use of Dermatologic Drugs and Infant Congenital Malformations

  • Chapter
  • First Online:
Maternal Drug Use and Infant Congenital Malformations

  • 406 Accesses

Abstract

Most dermatologic drugs are used topically. Some of these have been linked to a teratogenic risk but according to modern literature this seems to be unlikely which is supported by new data for some of the most commonly used such drugs, e.g., topical corticosteroids. Topically used retinoids (e.g., tretinoin) should be avoided during pregnancy but presently available data do not suggest a marked teratogenic risk. Systemic use of retinoids (notably isotretinoin) should be avoided during pregnancy. If such exposure has occurred, interruption of pregnancy should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barbero P, Lotersztein V, Bronberg R, Perez M, Alba L. Acitretin embryopathy: a case report. Birth Defects Res A Clin Mol Teratol. 2004;70:831–3.

    Article  CAS  Google Scholar 

  • Benke PJ. The isotretinoin teratogen syndrome. JAMA. 1984;251:3267–9.

    Article  CAS  Google Scholar 

  • Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects, Canada. Br J Clin Pharmacol. 2007;63:196–205.

    Article  Google Scholar 

  • Braun JT, Franciosi RA, Mastri AR, Drake RN, O’Neil BL. Isotretinoin dysmorphic syndrome. Lancet. 1984;1:506–7.

    Article  CAS  Google Scholar 

  • Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet. 1992;339:687.

    Article  CAS  Google Scholar 

  • Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ, for the National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197:585.e1–7.

    Article  Google Scholar 

  • Chi CC, Wang SH, Mayon-White R, Woynarowska F. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study. JAMA Dermatol. 2013;149:1274–80.

    Article  Google Scholar 

  • Chi CC, Wang SH, Wojnarowska F, Kirtshig G, Davies E, Bennet C. Safety of topical steroids in pregnancy. Cochrane Database Syst Rev. 2015;(10):CD007346. https://doi.org/10.1002/14651858.CD007346.pub3.

  • Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997;56:335–40.

    Article  CAS  Google Scholar 

  • Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A, Roddick G. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet. 2003;120A:459–63.

    Article  Google Scholar 

  • Garcia-Bournissen F, Tsur L, Goldstein H, Staroselsky A, Avner M, Asrar F, Berkovitch M, Straface G, Koreon G, De Santis M. Fetal exposure to isotretinoin—an international problem. Reprod Toxicol. 2008;25:124–8.

    Article  CAS  Google Scholar 

  • Gunnarskog JG, Källén AJB, Lindelöf BG, Sigurdiersson B. Psoralen photochemotherapy (PUVA) and pregnancy. Arch Dermatol. 1999;129:320–3.

    Article  Google Scholar 

  • Happle R, Traupe H, Bonameaux Y, Fisch T. Teratogene Wirkung von Etretinat beim Menschen. Dtsch Med Wochenschr. 1984;109:1476–7.

    Article  CAS  Google Scholar 

  • Hviid A, Molgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial cleft. CMAJ. 2011;183:796–804.

    Article  Google Scholar 

  • Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993;341:1181–2.

    Article  CAS  Google Scholar 

  • Kaler SG, Patrinos ME, Lampert GH, Myers TF, Karlman R, Anderson CL. Hypertrichosis and congenital malformations associated with maternal use of mixodil. Pediatrics. 1987;79:434–6.

    CAS  PubMed  Google Scholar 

  • Källén B. Drugs during pregnancy. New York: Nova Biomedical Books; 2009. p. 172.

    Google Scholar 

  • Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW, Lott IT, Richard JM, Sun SC. Retinoic acid embryopathy. N Engl J Med. 1985;313:837–41.

    Article  CAS  Google Scholar 

  • Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341:1352–3.

    Article  CAS  Google Scholar 

  • Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet. 2005;136A:117–21.

    Article  Google Scholar 

  • Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand. 2002;81:234–9.

    Article  Google Scholar 

  • Panchaud A, Csajka C, Merlob P, Schaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Stahl B, Rousso P, Winterfeld U, Rothuizen LE, Buclin T. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52:1844–51.

    Article  CAS  Google Scholar 

  • Rojansky N, Fasouliotis SJ, Ariel I, Nadjari M. Extreme caudal agenesis. Possible drug-related etiology? J Reprod Med. 2002;47:241–5.

    PubMed  Google Scholar 

  • Rosa FW. Teratogenicity of isotretinoin. Lancet. 1983;2:513.

    Article  CAS  Google Scholar 

  • Rosa FW, Idanpaan-Heikkila J, Asanti R. Fetal mixodil exposure. Pediatrics. 1987;80:120.

    CAS  PubMed  Google Scholar 

  • Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet. 2010;281:221–7.

    Article  Google Scholar 

  • Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet. 1997;350:1143.

    Article  CAS  Google Scholar 

  • Skuladottir H, Wilcox A, McConnaughey R, Vindenes H, Lie RT. First-trimester non-systemic corticosteroid use and the risk of oral clefts in Norway. Ann Epidemiol. 2014;24:635–40.

    Article  Google Scholar 

  • Smorlesi C, Caldarella A, Caramelli L, Di Lotto S, Moroni F. Topically applied minoxidil may cause fetal malformation. A case report. Birth Defects Res A Clin Mol Teratol. 2003;67:997–1001.

    Article  CAS  Google Scholar 

  • Stern RS, Lange R. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol. 1991;127:347–50.

    Article  CAS  Google Scholar 

  • Zarowny FW. Accutane Roche risk of teratogenic effects. Can Med Assoc J. 1984;131:273.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tornblad Institute for Comparative Embryology, Lund University, Lund, Sweden

    Bengt Källén

Authors
  1. Bengt Källén
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Källén, B. (2019). Maternal Use of Dermatologic Drugs and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17898-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17897-0

  • Online ISBN: 978-3-030-17898-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation